Latest Regulatory News

Page 630 of 765
Manuka Resources’ Taranaki VTM Project has cleared a key regulatory hurdle, moving forward in New Zealand’s Fast-track Approvals Process with promising economic and environmental prospects.
Maxwell Dee
Maxwell Dee
16 May 2025
Catalyst Metals has received the final environmental approval to begin mining at its Trident Gold Project, marking a key step in its plan to double production at the Plutonic Gold Belt.
Maxwell Dee
Maxwell Dee
16 May 2025
Tasman Resources Ltd has announced a renounceable pro-rata rights issue aiming to raise up to $3.68 million to finance exploration drilling at its Parkinson Dam project and reduce shareholder debt. Major shareholders plan to fully subscribe, using loan repayments to offset their entitlements.
Maxwell Dee
Maxwell Dee
16 May 2025
GPT Group and QuadReal Property Group have partnered to create a $1 billion logistics joint venture focused on Australia's east coast, aiming to expand their footprint in stabilised and core plus logistics assets.
Eva Park
Eva Park
15 May 2025
Mayne Pharma Group has proposed a $7.40 per share acquisition by Cosette Pharmaceuticals, with unanimous board support and a fair and reasonable opinion from an independent expert. Shareholders will vote on the scheme on June 18, 2025.
Ada Torres
Ada Torres
15 May 2025
HITIQ Limited has announced a non-renounceable entitlement offer to raise up to $2.92 million, supported by partial underwriting from GBA Capital and accompanied by new options issuance. The capital raise aims to fund expansion, product development, and operational growth.
Sophie Babbage
Sophie Babbage
15 May 2025
Sigma Healthcare has released its standalone annual and sustainability reports for the year ending January 2025, marking the final disclosures before its merger with Chemist Warehouse Group in February 2025.
Ada Torres
Ada Torres
15 May 2025
Embark Early Education announces a fully franked interim dividend and the conditional acquisition of two Queensland childcare centres, boosting its portfolio to 40 centres.
Victor Sage
Victor Sage
15 May 2025
Aspen Group has launched a $74 million equity raising to reduce debt and capitalize on growth opportunities in affordable housing, maintaining its FY25 earnings guidance.
Eva Park
Eva Park
15 May 2025
Mesoblast has been granted a seven-year orphan-drug exclusivity by the FDA for its cell therapy Ryoncil, reinforcing its market position in treating steroid-refractory acute graft versus host disease in children.
Ada Torres
Ada Torres
15 May 2025
Southern Cross Gold has successfully closed the second tranche of its C$143 million private placement, securing nearly C$30 million to fund critical milestones at its Sunday Creek Gold-Antimony Project in Australia.
Maxwell Dee
Maxwell Dee
15 May 2025
Peak Rare Earths is poised for acquisition by Shenghe Resources in a deal valuing the company at A$150.5 million, supported by a A$7.5 million entitlement offer to fund ongoing development and transaction costs.
Maxwell Dee
Maxwell Dee
15 May 2025